CLINICAL COURSE OF POLYPOUS RHINOSINUSITIS: CLINICAL ANALYSIS BASED ON INTERNATIONAL CLASSIFICATIONS
Keywords:
Keywords: CRSwNP, nasal polyps, type 2 inflammation, biologic therapy, EPOS 2020, eosinophilic rhinosinusitis, endotypingAbstract
Chronic rhinosinusitis with nasal polyps (CRSwNP) is a complex, relapsing inflammatory condition of the upper airways, substantially affecting patients' quality of life and respiratory function. This study presents a clinical analysis of 120 adult patients diagnosed with CRSwNP according to the EPOS 2020 criteria. We explore demographic characteristics, symptom profiles, endoscopic and imaging findings, laboratory biomarkers, and treatment outcomes over a 12-month follow-up period. Emphasis is placed on differentiating disease endotypes and phenotypes to better predict recurrence and response to therapy, including systemic corticosteroids and biologics. Our findings support the importance of precision medicine approaches in managing this heterogeneous disease.
References
1. Bachert C, Marple B, Schlosser RJ, et al. Adult chronic rhinosinusitis. Nat Rev Dis Primers. 2020.
2. Fokkens WJ, Lund VJ, Hopkins C, et al. EPOS 2020: European Position Paper on Rhinosinusitis and Nasal Polyps. Rhinology. 2020.
3. Stevens WW, Lee RJ, Schleimer RP, Cohen NA. Chronic rhinosinusitis pathogenesis. J Allergy Clin Immunol. 2015.
4. DeConde AS, Mace JC, Alt JA, et al. Predictors of revision sinus surgery. Int Forum Allergy Rhinol. 2017.
5. Laidlaw TM, Mullol J, Woessner KM, Amin N, Mannent LP. Biologics for nasal polyps. J Allergy Clin Immunol Pract. 2021.
6. Tomassen P, Vandeplas G, Van Zele T, et al. Inflammatory endotypes of CRSwNP. J Allergy Clin Immunol. 2016.
7. Han JK, Bachert C, Fokkens WJ, et al. Dupilumab in nasal polyposis. Lancet. 2019.
